| Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation SO Arulogun, HM Prince, J Ng, S Lade, GF Ryan, O Blewitt, C McCormack Blood, The Journal of the American Society of Hematology 112 (8), 3082-3087, 2008 | 209 | 2008 |
| Extracorporeal photopheresis for the treatment of Sezary syndrome using a novel treatment protocol S Arulogun, HM Prince, P Gambell, S Lade, G Ryan, E Eaton, ... Journal of the American Academy of Dermatology 59 (4), 589-595, 2008 | 47 | 2008 |
| Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy. O Tomkins, S Berentsen, S Arulogun, M Sekhar, S D'Sa | 24 | 2020 |
| Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID‐19 with B‐cell malignancies TA Fox, AA Kirkwood, L Enfield, M O'Reilly, S Arulogun, S D'Sa, J O'Nions, ... British Journal of Haematology 195 (5), 706, 2021 | 18 | 2021 |
| Recent treatment advances in Hodgkin lymphoma: a concise review S Arulogun, M Hertzberg, MK Gandhi Internal medicine journal 46 (12), 1364-1369, 2016 | 15 | 2016 |
| Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients C Buske, JJ Castillo, JP Abeykoon, R Advani, SO Arulogun, AR Branagan, ... Seminars in hematology 60 (2), 73-79, 2023 | 11 | 2023 |
| JAK1 Somatic Mutation in Myeloproliferative Neoplasm SO Arulogun, HC Lai, D Taylor, P Ambrosoli, G Magor, IM Irving, TB Keng, ... Blood 130, 5269, 2017 | 11 | 2017 |
| Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing SO Arulogun, D Brian, H Goradia, A Cooney, T Menne, RM Koo, ... American journal of hematology 98 (5), 750-759, 2023 | 5 | 2023 |
| Bendamustine plus rituximab for the treatment of Waldenström macroglobulinaemia: patient outcomes and impact of Bendamustine dosing SO Arulogun, D Brian, H Goradia, A Cooney, T Menne, D Talaulikar, ... Blood 136, 10-11, 2020 | 5 | 2020 |
| Before and after treatment characterization of cerebrospinal disease in Bing-Neel syndrome using 18F FDG PET/MRI S Riaz, D Priftakis, S Arulogun, S Wan, J Bomanji Clinical Nuclear Medicine 45 (9), 700-702, 2020 | 3 | 2020 |
| Pembrowm: results of a multi-centre phase Ii trial investigating the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory waldenström's macroglobulinaemia J Kothari, TA Eyre, A Rismani, H McCarthy, A Collins, DJ Lewis, ... Blood 140 (Supplement 1), 3624-3626, 2022 | 2 | 2022 |
| Clinicoradiopathological correlation of symptomatic focal bone marrow lesions in Waldenström Macroglobulinaemia SO Arulogun, MA Abbasi, S Pomplun, AT O’Neill, S Wan, A Wechalekar, ... Leukemia & Lymphoma 63 (6), 1496-1499, 2022 | 2 | 2022 |
| Real world experience on the use of ibrutinib monotherapy in waldenström macroglobulinemia O Ogunbiyi, SO Arulogun, A Patel, A Rismani, C Kyriakou, S D'Sa Blood 138, 4507, 2021 | 2 | 2021 |
| High-Dose Methotrexate Based Therapy for the Treatment of Bing Neel Syndrome SO Arulogun, MP Lunn, C Hoskote, A Carr, O Tomkins, A Rismani, ... Blood 136, 12-13, 2020 | 2 | 2020 |
| JAK1 somatic mutation in myeloproliferative neoplasm SO Arulogun, HC Lai, D Taylor, P Ambrosoli, G Magor, IM Irving, TB Keng, ... Pathology 50, S104-S105, 2018 | 2 | 2018 |
| IgM paraprotein-associated type 1 cryoglobulinaemia: clinical characteristics and outcomes J Khwaja, AS Patel, SO Arulogun, A Rismani, S Salter, C Kyriakou, ... Blood 138, 4503, 2021 | 1 | 2021 |
| Autologous Haematopoietic Stem Cell Transplantation in Waldenström Macroglobulinemia: A Single-Centre 18-Year Experience SO Arulogun, C Kyriakou, J Horder, F Newrick, AS Patel, A Rismani, ... Blood 138, 3548, 2021 | 1 | 2021 |
| Focal, Symptomatic Bone Marrow Lesions in Waldenström Macroglobulinaemia Characterised By Dense Infiltration with Lymphoplasmacytic Lymphoma: A Newly Defined Indication for … S Arulogun, MA Abbasi, S Pomplun, AT O'Neill, S Wan, I Kayani, S D'Sa Blood 136, 3-4, 2020 | 1 | 2020 |
| ABCL-048 Case Report: Hemophagocytic Lymphohistiocytosis With Central Nervous System Involvement A Mohsen, P Kottaridis, SO Arulogun Clinical Lymphoma Myeloma and Leukemia 23, S416, 2023 | | 2023 |
| POSTER: ABCL-048 Case Report: Hemophagocytic Lymphohistiocytosis With Central Nervous System Involvement A Mohsen, P Kottaridis, SO Arulogun Clinical Lymphoma Myeloma and Leukemia 23, S206, 2023 | | 2023 |
